Somatropin (recombinant human Growth Hormone) is primarily used to treat children with growth failure, prescribed for condition like kidney failure, Noonan syndrome, Turner syndrome, and others.
Recombinant hGH is manufactured in a EU/FDA cGMP approvable facility, and developed on a proprietary r-DNA platform technology using bacterial E. Coli. The ingredients used during the production are animal origin free.
EU CTD dossier is available.
Recombinant hGH is formulated in vials and ampules, with various concentrations, diluted or in sterile powder for dilution.
Recombinant hGH is also available in bulk ABS form ready for formulation in sterile fill and finish facilities.